Literature DB >> 18601653

Probing the interaction of tetraspanin CD151 with integrin alpha 3 beta 1 using a panel of monoclonal antibodies with distinct reactivities toward the CD151-integrin alpha 3 beta 1 complex.

Masashi Yamada1, Yumiko Tamura, Noriko Sanzen, Ryoko Sato-Nishiuchi, Hitoshi Hasegawa, Leonie K Ashman, Eric Rubinstein, María Yáñez-Mó, Francisco Sánchez-Madrid, Kiyotoshi Sekiguchi.   

Abstract

CD151, a member of the tetraspanin family of proteins, forms a stable complex with integrin alpha 3 beta 1 and regulates integrin-mediated cell-substrate adhesion. However, the molecular basis of the stable association of CD151 with integrin alpha 3 beta 1 remains poorly understood. In the present study, we show that a panel of anti-human CD151 mAbs (monoclonal antibodies) could be divided into three groups on the basis of their abilities to co-immunoprecipitate integrin alpha 3: Group-1 mAbs were devoid of sufficient activities to co-precipitate integrin alpha 3 under both low- and high-stringency detergent conditions; Group-2 mAbs co-precipitated integrin alpha 3 under low-stringency conditions; and Group-3 mAbs exhibited strong co-precipitating activities under both conditions. Group-1 mAbs in particular exhibited increased reactivity toward integrin alpha 3 beta 1-unbound CD151, indicating that the binding sites for Group-1 mAbs are partly blocked by bound integrin alpha 3 beta 1. Epitope mapping using a series of CD151 mutants with substitutions at amino acid residues that are not conserved between human and mouse CD151 revealed that Gly(176)/Gly(177), Leu(191) and Gln(194) comprise epitopes characteristic of Group-1 mAbs. Replacement of short peptide segments, each containing one of these epitopes, with those of other tetraspanins lacking stable interactions with integrin alpha 3 beta 1 demonstrated that the segment from Cys(185) to Cys(192), including Leu(191), was involved in the stable association of CD151 with integrin alpha 3 beta 1, as was the Gln(194)-containing QRD peptide. Taken together these results indicate that two consecutive segments including two Group-1 epitopes, Leu(191) and Gln(194), comprise an interface between CD151 and integrin alpha 3 beta 1, and, along with the epitope including Gly(176)/Gly(177), are concealed by bound integrin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18601653     DOI: 10.1042/BJ20071625

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  Structure-function analysis of tetraspanin CD151 reveals distinct requirements for tumor cell behaviors mediated by α3β1 versus α6β4 integrin.

Authors:  Shannin Zevian; Nicole E Winterwood; Christopher S Stipp
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

2.  New insights into the tetraspanin Tspan5 using novel monoclonal antibodies.

Authors:  Julien Saint-Pol; Martine Billard; Emmanuel Dornier; Etienne Eschenbrenner; Lydia Danglot; Claude Boucheix; Stéphanie Charrin; Eric Rubinstein
Journal:  J Biol Chem       Date:  2017-04-20       Impact factor: 5.157

Review 3.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

5.  Plasma membrane proteoglycans syndecan-2 and syndecan-4 engage with EGFR and RON kinase to sustain carcinoma cell cycle progression.

Authors:  DeannaLee M Beauvais; Scott E Nelson; Kristin M Adams; Noah A Stueven; Oisun Jung; Alan C Rapraeger
Journal:  J Biol Chem       Date:  2022-05-13       Impact factor: 5.486

6.  Profiling Cysteine Reactivity and Oxidation in the Endoplasmic Reticulum.

Authors:  Tyler J Bechtel; Chun Li; Eleni A Kisty; Aaron J Maurais; Eranthie Weerapana
Journal:  ACS Chem Biol       Date:  2020-01-15       Impact factor: 5.100

7.  Integrin-free tetraspanin CD151 can inhibit tumor cell motility upon clustering and is a clinical indicator of prostate cancer progression.

Authors:  Trenis D Palmer; Carlos H Martínez; Catalina Vasquez; Katie E Hebron; Celestial Jones-Paris; Shanna A Arnold; Susanne M Chan; Venu Chalasani; Jose A Gomez-Lemus; Andrew K Williams; Joseph L Chin; Giovanna A Giannico; Tatiana Ketova; John D Lewis; Andries Zijlstra
Journal:  Cancer Res       Date:  2013-11-12       Impact factor: 12.701

8.  JAM-A interacts with α3β1 integrin and tetraspanins CD151 and CD9 to regulate collective cell migration of polarized epithelial cells.

Authors:  Sonja Thölmann; Jochen Seebach; Tetsuhisa Otani; Luise Florin; Hans Schnittler; Volker Gerke; Mikio Furuse; Klaus Ebnet
Journal:  Cell Mol Life Sci       Date:  2022-01-24       Impact factor: 9.261

Review 9.  Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.

Authors:  Felipe Vences-Catalán; Shoshana Levy
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

10.  miR-506 regulates epithelial mesenchymal transition in breast cancer cell lines.

Authors:  Himanshu Arora; Rehana Qureshi; Woong-Yang Park
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.